Neuropsychiatric Disease and Treatment,
Journal Year:
2018,
Volume and Issue:
Volume 15, P. 95 - 103
Published: Dec. 1, 2018
Abstract:
Seizures
and
epilepsy
are
quite
a
common
outcome
of
arterial
ischemic
stroke
(AIS)
both
in
pediatric
adult
patients,
with
distinctly
higher
occurrence
children.
These
poststroke
consequences
affect
patients'
lives,
often
causing
disability.
Poststroke
seizure
(PSS)
may
also
increase
mortality
patients
AIS.
Early
PSS
(EPSS)
occurring
up
to
7
days
after
AIS,
late
(LPSS)
2
years
the
onset
as
well
(PSE)
can
be
distinguished.
However,
exact
definition
cutoff
point
for
PSE
should
determined.
A
wide
range
risk
factors
seizures
AIS
still
being
detected
analyzed.
More
accurate
knowledge
on
possible
prediction
epileptic
have
an
impact
improving
prevention
treatment
PSE.
The
aim
present
review
was
discuss
current
perspectives
diagnosis
PSE,
paediatric
patients.
Keywords:
stroke,
early
seizures,
antiepileptic
Acta Epileptologica,
Journal Year:
2022,
Volume and Issue:
4(1)
Published: Jan. 4, 2022
Abstract
Stroke
is
the
most
frequent
cause
of
secondary
epilepsy
in
elderly.
The
incidence
cerebral
stroke
increasing
with
extension
life
expectancy,
and
prevalence
post-stroke
(PSE)
rising.
There
are
various
seizure
types
after
stroke,
occurrence
closely
related
to
type
location
stroke.
Moreover,
clinical
treatment
difficult,
which
increases
risk
disability
death,
affects
prognosis
quality
patients.
Now
more
get
attention
medical
profession,
has
been
researchers
have
devoted
seizures
PSE
basic
research,
hope
a
scientific
unified
guideline,
give
timely
effective
treatment,
but
exact
pathophysiologic
mechanism
not
yet
formed
conclusion.
It
found
that
ion
channels,
neurotransmitters,
proliferation
glial
cells,
genetics
other
factors
involved
development
PSE.
In
this
review,
we
discuss
pathogenesis
early-onset
epileptic
late-onset
order
provide
basis
for
clinicians
understand
disease,
expect
ideas
future
exploration.
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(10), P. 1844 - 1844
Published: Oct. 10, 2023
The
aim
of
this
review
is
to
explore
the
relationship
between
melatonin,
free
radicals,
and
non-excitatory
amino
acids,
their
role
in
stroke
aging.
Melatonin
has
garnered
significant
attention
recent
years
due
its
diverse
physiological
functions
potential
therapeutic
benefits
by
reducing
oxidative
stress,
inflammation,
apoptosis.
been
found
mitigate
ischemic
brain
damage
caused
stroke.
By
scavenging
radicals
damage,
melatonin
may
help
slow
down
aging
process
protect
against
age-related
cognitive
decline.
Additionally,
acids
have
shown
possess
neuroprotective
properties,
including
antioxidant
anti-inflammatory
aging-related
conditions.
They
can
attenuate
modulate
calcium
homeostasis,
inhibit
apoptosis,
thereby
safeguarding
neurons
induced
processes.
intracellular
accumulation
certain
could
promote
harmful
effects
during
hypoxia-ischemia
episodes
thus,
blockade
acid
transporters
involved
be
an
alternative
strategy
reduce
damage.
On
other
hand,
specifically
mitochondrial
reactive
oxygen
nitrogen
species,
accelerates
cellular
senescence
contributes
Recent
research
suggests
a
complex
interplay
actions
converge
on
multiple
pathways,
regulation
modulation
reduction
inflammation.
These
mechanisms
collectively
contribute
preservation
neuronal
integrity
functions,
making
them
promising
targets
for
interventions
disorders.
Neurology,
Journal Year:
2019,
Volume and Issue:
93(6)
Published: July 11, 2019
Objective
Our
study
objectives
were
to
identify
factors
associated
with
new-onset
epilepsy
and
refractory
among
older
adult
stroke
survivors
evaluate
the
receipt
of
diagnostic
care
mortality
for
participants
who
developed
epilepsy.
Methods
We
conducted
a
population-based,
retrospective
cohort
using
linked,
administrative
health
databases.
The
Ontario
Stroke
Registry
was
used
patients
67
years
hospitalized
at
designated
center
in
Ontario,
Canada,
between
April
1,
2003,
March
31,
2009,
previously
free
Multivariable
Fine–Gray
hazard
models
examine
risk
epilepsy,
accounting
competing
death.
Results
Among
19,138
adults
stroke,
210
(1.1%)
27
(12.9%)
became
antiepileptic
drugs.
Within
1
year
diagnosis,
24
(11.4%)
assessed
EEG
19
(9.0%)
MRI.
In
multivariable
analysis,
younger
age
thrombolysis
significantly
increased
risk.
Lesser
severity
anticoagulant
medication
also
risk;
however,
these
effects
decreased
over
time.
Younger
female
sex
only
5
following
97
(46.2%)
died
any
cause.
Conclusions
Older
are
less
likely
develop
pharmacologically
An
estimated
86.6%
deaths
attributed
causes
other
than
or
Frontiers in Neurology,
Journal Year:
2020,
Volume and Issue:
10
Published: Jan. 23, 2020
The
effects
of
thrombolysis
in
seizure
and
epilepsy
after
acute
ischemic
stroke
have
been
poorly
explored.
In
this
study,
we
examine
risk
factors
consequences
intravenous
rt-PA
for
treatment
stroke.
a
retrospective
cohort
study
evaluate
thrombolysis,
as
well
the
impact
seizures
outcome
patients.
our
cohort,
mean
age
patients
was
67.2
years
old
(SD
=
13.1)
79
them
(51.6%)
were
male
and.
Initial
NIHSS
score
10.95
6.25).
Three
months
2.09
3.55).
Eighty
seven
(56.9%)
mRS
0-1
thrombolysis.
Hemorrhagic
transformation
observed
22
(14.4%)
Twenty-one
(13.7%)
had
15
(9.8%)
developed
Seizures
independently
associated
with
hemorrhagic
(OR
3.26;
95%
CI
1.08-9.78;
p
0.035)
≥
2
at
3
3.51;
1.20-10.32;
0.022).
3.55;
1.11-11.34;
0.033)
5.82;
1.45-23.42;
0.013)
variables
post-stroke
epilepsy.
independent
risks
poor
1.03;
1.01-1.06;
0.011),
higher
1.08;
1.03-1.14;
0.001),
2.33;
1.11-4.76;
0.024),
3.07;
1.22-7.75;
0.018)
large
cortical
area
(ASPECTS
≤
7)
2.04;
1.04-3.84;
0.036).
Concluding,
neurological
impairment
(but
not
before)
remained
or
Moreover,
that
emerged
an
factor
therapy
0.018).
Brain and Behavior,
Journal Year:
2021,
Volume and Issue:
11(9)
Published: Aug. 22, 2021
Abstract
Background
and
purpose
The
management
of
post‐stroke
epilepsy
(PSE)
should
ideally
include
prevention
both
seizure
adverse
effects;
however,
an
optimal
antiseizure
medications
(ASM)
regimen
has
yet
been
established.
this
study
is
to
assess
recurrence,
retention,
tolerability
older‐generation
newer‐generation
ASM
for
PSE.
Methods
This
prospective
multicenter
cohort
(PROgnosis
Post‐Stroke
Epilepsy
[PROPOSE]
study)
was
conducted
from
November
2014
September
2019
at
eight
hospitals.
A
total
372
patients
admitted
treated
with
discharge
were
recruited.
Due
the
non‐interventional
nature
study,
not
adjusted
followed
standard
hospital
practices.
primary
outcome
recurrence
in
receiving
ASM.
secondary
outcomes
retention
regimens.
Results
Of
PSE
(median
[IQR]
age,
73
[64–81]
years;
139
women
[37.4%]),
36
older‐generation,
286
newer‐generation,
50
mixed‐generation
In
older‐
groups
(
n
=
322),
98
(30.4%)
had
recurrent
seizures
91
(28.3%)
switched
during
follow‐up
(371
[347–420]
days).
Seizure
lower
compared
(hazard
ratio
[HR],
0.42,
95%CI
0.27–0.70;
p
.0013).
withdrawal
change
dosages
(HR,
0.34,
95%
CI
0.21–0.56,
<
.0001).
Conclusions
Newer‐generation
possess
advantages
over
prophylaxis
clinical
practice.
Epilepsia,
Journal Year:
2023,
Volume and Issue:
64(11), P. 2878 - 2890
Published: Sept. 19, 2023
Abstract
Background
With
the
unanimous
approval
of
Intersectoral
Global
Action
Plan
on
epilepsy
and
other
neurological
disorders
by
World
Health
Organization
in
May
2022,
there
are
strong
imperatives
to
work
towards
equitable
care.
Aims
Using
as
an
entry
point
neurologic
conditions,
we
discuss
disparities
faced
marginalized
groups
including
racial/ethnic
minorities,
Americans
living
rural
communities,
with
low
socioeconomic
status.
Materials
Methods
The
National
Institute
Minority
Disparities
Research
Framework
(NIMHD)
was
used
conduct
a
narrative
review
through
health
equity
lens
create
adapted
framework
for
propose
approaches
working
Results
In
this
review,
identified
priority
populations
(racial
ethnic
minority,
rural‐residing,
status
persons
epilepsy)
outcomes
(likelihood
see
neurologist,
be
prescribed
antiseizure
medications,
undergo
surgery,
hospitalized)
explore
guide
our
focused
literature
search
using
PubMed.
NIMHD
framework,
examined
individual,
interpersonal,
community,
societal
level
contributors
across
five
domains:
(1)
behavioral,
(2)
physical/built
environment,
(3)
sociocultural,
(4)
(5)
healthcare
system.
We
take
approach
initiatives
that
target
modifiable
factors
impact
advocate
sustainable
change
populations.
Discussion
To
improve
equity,
providers
relevant
stakeholders
can
improved
care
coordination,
referrals
access
care,
informatics
interventions,
education
(i.e.,
providers,
patients,
communities).
More
broadly,
reforms
medical
education,
American
insurance
landscape.
Conclusions
Equitable
should
Journal of Pharmacology and Experimental Therapeutics,
Journal Year:
2023,
Volume and Issue:
388(2), P. 301 - 312
Published: Oct. 12, 2023
Organophosphate
(OP)
poisoning
can
trigger
cholinergic
crisis,
a
life-threatening
toxidrome
that
includes
seizures
and
status
epilepticus.
These
acute
toxic
responses
are
associated
with
persistent
neuroinflammation
spontaneous
recurrent
(SRS),
also
known
as
acquired
epilepsy.
Blood-brain
barrier
(BBB)
impairment
has
recently
been
proposed
pathogenic
mechanism
linking
OP
intoxication
to
chronic
adverse
neurologic
outcomes.
In
this
review,
we
briefly
describe
the
cellular
molecular
components
of
BBB,
review
evidence
altered
BBB
integrity
following
intoxication,
discuss
potential
mechanisms
by
which
may
promote
dysfunction.
We
highlight
complex
interplay
between
dysfunction
suggests
positive
feedforward
interaction.
Lastly,
examine
research
from
diverse
models
disease
states
suggest
loss
contribute
epileptogenic
processes.
Collectively,
literature
identifies
convergent
justifies
further
mechanistic
into
how
causes
its
role
in
pathogenesis
SRS
potentially
other
long-term
sequelae.
Such
is
critical
for
evaluating
stabilization
neuroprotective
strategy
mitigating
OP-induced
epilepsy
possibly
seizure
disorders
etiologies.
SIGNIFICANCE
STATEMENT:
Clinical
preclinical
studies
support
link
blood-brain
epileptogenesis;
however,
causal
relationship
difficult
prove.
Mechanistic
delineate
relationships
provide
novel
insights
resulting
organophosphate
non-OP
neurological
conditions
such
cognitive
impairment.
Neurology,
Journal Year:
2025,
Volume and Issue:
104(3)
Published: Jan. 14, 2025
The
most
effective
antiseizure
medications
(ASMs)
for
poststroke
seizures
(PSSs)
remain
unclear.
We
aimed
to
determine
outcomes
associated
with
ASMs
in
people
PSS.
systematically
searched
electronic
databases
studies
on
patients
PSS
ASMs.
Our
were
seizure
recurrence,
adverse
events,
drug
discontinuation
rate,
and
mortality.
assessed
the
risk
of
bias
using
Cochrane
Risk
Bias
tool
randomized
controlled
trials
Of
In
Non-randomized
Studies
Interventions
tools.
Using
levetiracetam
as
reference
treatment,
we
conducted
a
frequentist
network
meta-analysis
determined
certainty
evidence
Grading
Recommendations
Assessment,
Development,
Evaluation
methodology.
search
yielded
15
(3
randomized,
12
nonrandomized,
N
=
18,676
(121
early
18,547
late
seizures),
60%
male,
mean
age
69
years)
comparing
13
Three
had
moderate
high
bias.
Seizure
recurrence
was
24.8%.
Compared
levetiracetam,
very
low-certainty
suggested
that
phenytoin
higher
recurrences
(odds
ratio
[OR]
7.3,
95%
CI
3.7-14.5)
more
events
(OR
5.2,
1.2-22.9).
Low-certainty
carbamazepine
1.8,
1.5-2.2)
1.9,
1.4-2.8)
rates.
Moderate
high-certainty
valproic
acid
4.7,
3.6-6.3)
8.3,
5.7-11.9)
mortality
Considering
all
treatments
GRADE
approach
treatment
ranking,
eslicarbazepine,
lacosamide,
fewest
recurrences.
Low
lamotrigine
discontinuations,
whereas
exhibited
low
rates
moderate-certainty
evidence.
found
may
be
safe
tolerable
Despite
ASM
use,
rate
remains
population.
Owing
confounding
risks,
these
findings
should
interpreted
cautiously.
PROSPERO:
CRD42022363844.
Quantitative Imaging in Medicine and Surgery,
Journal Year:
2025,
Volume and Issue:
15(2), P. 1175 - 1189
Published: Jan. 24, 2025
Post-stroke
epilepsy
(PSE)
is
a
common
and
significant
complication
that
often
occurs
after
stroke,
affects
patients'
prognosis
overall
quality
of
life.
In
recent
years,
non-contrast
computed
tomography
(NCCT)
has
become
the
preferred
method
for
clinical
diagnosis
intracerebral
hemorrhage
(ICH).
This
study
aimed
to
develop
validate
triple
deep-learning
model,
simply
named,
post-stroke
network
(PSENet),
predict
PSE
in
ICH
patients
based
on
NCCT.
A
total
1,130
(62
with
1,068
without
PSE)
who
experienced
an
initial
at
our
hospital
were
enrolled
this
study.
Using
five-fold
cross-validation,
all
randomly
divided
into
training
validation
sets
ratio
4:1.
Next,
no-new-Net
(nnU-Net)
was
used
automatically
segment
subsequent
quantitative
analysis.
model
developed
extract
PSE-related
features
incorporate
related
cortical
involvement
(FCI)
volume
PSE.
compared
three
models
constructed
using
random
forest.
Model
performance
mainly
evaluated
area
under
curve
(AUC).
The
nnU-Net
had
high
Dice
score
0.923.
proposed
PSENet,
which
incorporated
multiple
features,
showed
excellent
diagnostic
performance,
accuracy
0.876,
F1-score
0.621,
recall
0.716,
specificity
0.897,
AUC
0.840,
significantly
surpassed
baseline
(AUC
=0.787).
Based
findings,
PSENet
could
be
quickly
first
ICH,
especially
scenarios
reliable
information
lacking
admission.